Skip to main content

MoneyWorks4Me

Glenmark Pharmaceuticals informs about media release

06 Oct 2026 Evaluate
Glenmark Pharmaceuticals has informed that, Glenmark Therapeutics Inc., USA (Glenmark) is pleased to announce the launch1 of Adapalene Gel USP, 0.1% (OTC) in new pump packs. Glenmark’s Adapalene Gel USP, 0.1% can be compared to the active ingredient of Differin®2 Gel, 0.1%. According to Nielsen® syndicated data for the latest 52-week period ending September 5, 2026, the Differin® Gel, 0.1% (OTC) market3 achieved annual sales of approximately $45.8 million*. The company has attached media release in this regard. 

The above information is a part of company’s filings submitted to BSE. 
Peers
Company Name CMP
Sun Pharma. Inds. 1870.30
Dr. Reddys Labs. 1383.30
Cipla 1389.95
Lupin 1951.80
Zydus Lifesciences 1202.70
View more..